Extract
Assessment of jugular venous pressure (JVP) is a classic physical exam maneuver that serves as an estimate of right atrial pressure (RAP). Although JVP was rated by experts as the most important physical exam finding to monitor response to therapy in pulmonary hypertension (PH) patients [1], it has been understudied in PH. Since RAP is an accurate predictor of outcome in PH [2, 3], determining whether clinically assessed JVP (as a non-invasive surrogate for RAP) also predicts outcomes is an important, unanswered question. Since JVP can be difficult to measure on physical exam due to obesity and challenges distinguishing between carotid and jugular pulsations, ultrasound measures of JVP have been developed [4, 5]. We hypothesized that: 1) JVP measurement could be more reliably obtained by ultrasound (JVP-US) than JVP by physical exam (JVP-exam); 2) JVP-US would correlate with same-day B-type natriuretic peptide (BNP), another non-invasive surrogate of right heart function; and 3) JVP-US would predict time to clinical worsening (TTCW).
Footnotes
This manuscript has recently been accepted for publication in theEuropean Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of theERJonline. Please open or download the PDF to view this article.
Conflict of interest: Dr. Lammi has nothing to disclose.
Conflict of interest: Dr. Samant has nothing to disclose.
Conflict of interest: Dr. Tran has nothing to disclose.
- ReceivedSeptember 29, 2021.
- AcceptedOctober 29, 2021.
- Copyright ©The authors 2021. For reproduction rights and permissions contactpermissions{at}ersnet.org